Advertisement
Advertisement

QNRX

QNRX logo

Quoin Pharmaceuticals, Ltd. - ADR

7.33
USD
Sponsored
-0.50
-6.33%
Feb 06, 15:56 UTC -5
Closed
exchange

After-Market

7.48

+0.16
+2.12%

QNRX Earnings Reports

Positive Surprise Ratio

QNRX beat 14 of 21 last estimates.

67%

Next Report

Date of Next Report
Mar 11, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$3.40
Implied change from Q3 25 (Revenue/ EPS)
--
/
-49.33%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-72.24%

Quoin Pharmaceuticals, Ltd. - ADR earnings per share and revenue

On Nov 06, 2025, QNRX reported earnings of -6.71 USD per share (EPS) for Q3 25, missing the estimate of -5.07 USD, resulting in a -32.19% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -11.19% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -3.40 USD, with revenue projected to reach -- USD, implying an decrease of -49.33% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Quoin Pharmaceuticals, Ltd. - ADR reported EPS of -$6.71, missing estimates by -32.19%, and revenue of $0.00, 0% as expectations.
The stock price moved down -11.19%, changed from $9.65 before the earnings release to $8.57 the day after.
The next earning report is scheduled for Mar 11, 2026.
Based on 5 analysts, Quoin Pharmaceuticals, Ltd. - ADR is expected to report EPS of -$3.40 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement